449 related articles for article (PubMed ID: 20637325)
1. Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway.
Uemura T; Ohta Y; Nakao Y; Manaka T; Nakamura H; Takaoka K
Bone; 2010 Oct; 47(4):756-65. PubMed ID: 20637325
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation.
Nakagawa K; Imai Y; Ohta Y; Takaoka K
Bone; 2007 Oct; 41(4):543-8. PubMed ID: 17681894
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
[TBL] [Abstract][Full Text] [Related]
5. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells.
Mikami Y; Asano M; Honda MJ; Takagi M
J Cell Physiol; 2010 Apr; 223(1):123-33. PubMed ID: 20039267
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of cAMP-dependent protein kinase inhibitor gamma is required for BMP-2-induced osteoblastic differentiation.
Zhao L; Yang S; Zhou GQ; Yang J; Ji D; Sabatakos G; Zhu T
Int J Biochem Cell Biol; 2006; 38(12):2064-73. PubMed ID: 16870489
[TBL] [Abstract][Full Text] [Related]
8. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells.
Singhatanadgit W; Salih V; Olsen I
Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965
[TBL] [Abstract][Full Text] [Related]
9. cAMP enhances BMP2-signaling through PKA and MKP1-dependent mechanisms.
Ghayor C; Ehrbar M; San Miguel B; Grätz KW; Weber FE
Biochem Biophys Res Commun; 2009 Apr; 381(2):247-52. PubMed ID: 19217886
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo.
Chikazu D; Li X; Kawaguchi H; Sakuma Y; Voznesensky OS; Adams DJ; Xu M; Hoshio K; Katavic V; Herschman HR; Raisz LG; Pilbeam CC
J Bone Miner Res; 2002 Aug; 17(8):1430-40. PubMed ID: 12162497
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
13. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
14. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
17. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
[TBL] [Abstract][Full Text] [Related]
18. Involvement of phosphodiesterase isozymes in osteoblastic differentiation.
Wakabayashi S; Tsutsumimoto T; Kawasaki S; Kinoshita T; Horiuchi H; Takaoka K
J Bone Miner Res; 2002 Feb; 17(2):249-56. PubMed ID: 11811555
[TBL] [Abstract][Full Text] [Related]
19. Low-level laser irradiation enhances BMP-induced osteoblast differentiation by stimulating the BMP/Smad signaling pathway.
Hirata S; Kitamura C; Fukushima H; Nakamichi I; Abiko Y; Terashita M; Jimi E
J Cell Biochem; 2010 Dec; 111(6):1445-52. PubMed ID: 20830741
[TBL] [Abstract][Full Text] [Related]
20. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
